Tata Mid Cap Fund
Direct · GrowthAI Summary
Tata Mid Cap Fund has delivered a 3Y SIP XIRR of 21.6% and 5Y XIRR of 20.67%, modestly ahead of category averages of 19.93% and 19.38% respectively, though its 1Y XIRR of 15.58% trails the category average of 21.6%. Over longer horizons, the fund has been broadly in line with peers, with 10Y XIRR of 19.44% versus the category's 19.41%. Against the NIFTY MIDCAP 150, the fund shows positive alpha across most periods, including 1.41% over 1Y and 2.83% over 15Y, though it lags the benchmark CAGR over 3Y (17.52% vs 18.08%) and 5Y (16.46% vs 17.46%).
The fund exhibits a beta of roughly 0.88-0.91 across periods, indicating it moves slightly less than the benchmark in both directions, with downside capture consistently below upside capture (e.g., 86.99% upside vs 84.36% downside over 1Y). It has experienced 9 drawdown events greater than 10%, reflecting the inherent volatility of the mid-cap segment. Calmar ratios between 0.51 and 0.67 across horizons suggest reasonable risk-adjusted returns relative to peak-to-trough losses.
The portfolio holds 63 stocks with a well-diversified top 10 accounting for roughly 25% of NAV, led by Mankind Pharma (3.47%) and Federal Bank (3.37%). Banks is the largest sector at 12.3%, followed by Pharmaceuticals & Biotechnology at 8.6% and Auto Components at 7.9%, giving meaningful but not extreme concentration. Exposure spans financials, healthcare, capital markets, and telecom services, providing reasonable sector balance for a mid-cap mandate.
The fund outperforms the category average SIP XIRR over 3Y (21.6% vs 19.93%) and 5Y (20.67% vs 19.38%), while matching peers over 10Y and trailing over 1Y (15.58% vs 21.6%). Calendar year returns show strong consistency in favorable years, including 49.52% in 2017, 41.47% in 2023, and 40.68% in 2021, with contained losses of -12.04% in 2018 and -2.11% in 2016. Its long-term alpha of 2.83% over 15Y suggests durable benchmark outperformance over extended holding periods.
This fund suits investors seeking mid-cap growth exposure with a time horizon of at least 5-7 years, as shorter periods show more variable results versus peers. Investors should have a high risk tolerance given 9 drawdown events exceeding 10% and calendar year swings from -12.04% to +80.96%. A SIP approach is appropriate given the fund's strong 3Y and 5Y SIP XIRR relative to category averages.
- 3Y SIP XIRR of 21.6% and 5Y XIRR of 20.67% both exceed category averages of 19.93% and 19.38%
- Consistently positive alpha versus NIFTY MIDCAP 150, including 2.83% over 15Y and 1.70% over 12Y
- Downside capture below upside capture across all periods, indicating better loss containment than gain participation shortfall
- 1Y SIP XIRR of 15.58% significantly trails the category average of 21.6%
- Fund CAGR lags the benchmark over 3Y (17.52% vs 18.08%) and 5Y (16.46% vs 17.46%)
- Nine drawdown events exceeding 10% highlight substantial volatility typical of mid-cap funds
Generated on 06-09-2026, 8:05 PM. Verify before investing.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.91 L | 24.8% | -49.1% | 131.3% |
| 3 Years | ₹36.00 L | ₹47.31 L | 19.0% | -17.6% | 42.8% |
| 5 Years | ₹60.00 L | ₹95.52 L | 18.4% | -6.0% | 34.6% |
| 7 Years | ₹84.00 L | ₹1.65 Cr | 18.8% | 3.4% | 28.1% |
| 10 Years | ₹1.20 Cr | ₹3.26 Cr | 19.3% | 15.9% | 23.1% |
| 12 Years | ₹1.44 Cr | ₹4.84 Cr | 18.9% | 16.2% | 21.8% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY MIDCAP 150 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 24.8% | 22.0% | 21.6% | +2.8% |
| 3 Years | 19.0% | 17.3% | 19.9% | +1.7% |
| 5 Years | 18.4% | 16.5% | 19.4% | +1.9% |
| 7 Years | 18.8% | 16.8% | 19.3% | +2.0% |
| 10 Years | 19.3% | 16.6% | 19.4% | +2.7% |
| 12 Years | 18.9% | 16.3% | 18.8% | +2.5% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 23.6% | 15.5% | -26.6% | 106.6% | 0.63 | 2.93 | 84% | — | — |
| 3 Years | 19.8% | 21.5% | -4.1% | 40.3% | 1.50 | 9.52 | 98% | — | — |
| 5 Years | 18.7% | 18.5% | 0.5% | 32.9% | 1.83 | 22.18 | 100% | — | — |
| 10 Years | 19.1% | 18.7% | 14.4% | 23.9% | 5.27 | — | 100% | — | — |
Calmar Ratio by Duration
Compared against NIFTY MIDCAP 150
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +1.41 | 0.88 | 87.0% | 84.4% | 10.9% | 9.9% |
| 3 Years | +0.85 | 0.88 | 87.1% | 85.3% | 17.5% | 18.1% |
| 5 Years | +0.18 | 0.89 | 89.3% | 88.3% | 16.5% | 17.5% |
| 7 Years | +0.95 | 0.91 | 90.5% | 88.8% | 21.7% | 22.1% |
| 10 Years | +1.22 | 0.90 | 89.1% | 87.0% | 17.0% | 16.8% |
| 12 Years | +1.70 | 0.90 | 89.5% | 87.0% | 17.6% | 16.9% |
| 15 Years | +2.83 | 0.89 | 89.0% | 85.1% | 17.3% | 15.4% |
| # | Stock | % of NAV |
|---|---|---|
| 1 | MANKIND PHARMA LTD | 3.47% |
| 2 | FEDERAL BANK LTD | 3.37% |
| 3 | BHARAT HEAVY ELECTRICALS LTD | 3.19% |
| 4 | MAX FINANCIAL SERVICES LTD | 2.70% |
| 5 | INDUSIND BANK LTD | 2.68% |
| 6 | AU SMALL FINANCE BANK LTD | 2.65% |
| 7 | BSE LTD | 2.58% |
| 8 | INDIAN BANK | 2.55% |
| 9 | MARICO LTD | 2.49% |
| 10 | INDUS TOWERS LTD | 2.34% |